Delivery Order SPE2DB20D2104-SPE2DB24FS24H
Award Date
1/25/24
Potential Completion Date
1/26/24
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,652.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product.
The contract is structured as a Delivery Order, with a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating open competition. The award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $8,275.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4556519749 - DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $178,876.31 for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has an ultimate completion date of January 30, 2024.
The contract is a Firm Fixed Price arrangement and was awarded without any set-aside designation, indicating open competition....
This federal contract award is a Delivery Order (DO) valued at $14,954.42, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The DO is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML and has a completion date of January 12, 2024.
The award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The $13,285.33 Firm Fixed Price delivery order is for the specialty pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of January 18, 2022 and was awarded on January 14, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $13,063.17 for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, on April 29, 2024, with a completion date of April 30, 2024. This delivery order is under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $8,564.80 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4558509702 - DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a pharmaceutical product, with a completion date of September 20, 2022.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as...
This federal contract award, valued at $10,262.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563635171 DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract is a firm-fixed-price Delivery Order with a period of performance through February 13, 2024.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $21,787.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This is a Firm Fixed Price delivery order contract with a completion date of February 5, 2024. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, valued at $21,544.69, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a completion date of December 13, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...